ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 245.00
-5.60 (-2.23%)
Jun 30, 2026, 4:16 PM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 55.52 billion as of June 30, 2026. Its market cap has increased by 33.88% in one year.
Market Cap
55.52B
Enterprise Value
54.39B
Revenue
6.56B
Ranking
n/a
PE Ratio
43.37
Stock Price
245.00
Market Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 55.52B, an increase of 703.75%. That is a compound annual growth rate of 10.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 55.52B | 9.81% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.41T |
| Genmab | 104.49B |
| Coloplast | 85.99B |
| Demant | 56.10B |
| H. Lundbeck | 40.51B |
| Zealand Pharma | 20.00B |
| Ambu A/S | 16.08B |
| Bavarian Nordic | 13.69B |